Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

IMAX CORP

CIK 921582Updated Sep 27, 2026

IMAX price & chart

Provider market data

Loading TradingView…

NYSE:IMAX on TradingView ↗

TradingView · Data may be delayed

About the company

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.

8-K · 2025-11-06 · 0001193125-25-270049

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue410,212,000USD · FY 2025
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

Net income34,876,000USD · FY 2025
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

Operating income84,229,000USD · FY 2025
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

Diluted EPS0.63USD per share · FY 2025
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD894,031,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

830,398,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

814,669,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

821,154,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Property, Plant and Equipment, NetUSD242,910,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

240,133,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

243,299,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

252,896,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

GoodwillUSD45,815,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

52,815,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

52,815,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

52,815,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Intangible Assets, Net (Excluding Goodwill)USD32,391,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

35,124,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

35,022,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

32,738,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD151,168,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

100,592,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

76,200,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

97,401,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD108,079,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

107,669,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

136,259,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

136,142,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Inventory, NetUSD32,505,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

32,840,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

31,584,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

31,534,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD9,300,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

10,019,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

10,599,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

12,341,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD466,298,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

452,183,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

469,080,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

491,386,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD419,162,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

401,420,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

389,048,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

376,715,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-239,967,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

-274,675,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

-292,845,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

-293,124,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-10,305,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

-16,598,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

-12,081,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

-9,846,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD337,891,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

299,466,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

273,141,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

263,355,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Additional Paid in Capital, Common StockUSD164,782,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

185,268,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

185,087,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

185,678,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Liabilities and EquityUSD894,031,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

830,398,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

814,669,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

821,154,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Deferred Income Tax Liabilities, NetUSD12,521,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

12,521,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

12,521,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

14,900,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD89,176,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

78,069,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

71,790,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

65,691,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Additional Financial Items
Deferred Tax Liabilities, NetUSD——4,533,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

5,000,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD666,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

680,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

658,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

722,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD45,526,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

32,702,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

33,066,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-19,877,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization————
Share-based Payment Arrangement, Noncash ExpenseUSD26,600,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

22,800,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

23,600,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

27,000,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD1,319,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-29,105,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

1,907,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

29,003,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts PayableUSD-481,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-6,383,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-535,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

8,496,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD772,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-5,631,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-1,447,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-2,073,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD127,068,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

70,837,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

58,615,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

17,321,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD—0
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

—15,939,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Investing ActivitiesUSD-41,916,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-41,216,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-31,790,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-53,291,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD8,167,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

8,428,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

6,491,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

8,424,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD9,742,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

4,978,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

6,466,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

3,687,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Financing ActivitiesUSD-34,079,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-6,041,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-48,530,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-58,514,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD50,576,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

24,392,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-21,201,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-92,310,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD4,876,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

5,723,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

3,930,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

715,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD15,853,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

———
Additional Financial Items
AmortizationUSD——60,022,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

56,661,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, ExpenseUSD26,578,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

22,821,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

23,551,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

27,013,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Amortization of Deferred ChargesUSD——20,281,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

16,881,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Amortization of Debt Issuance CostsUSD1,984,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

1,969,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

2,235,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

3,177,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Amortization of Intangible AssetsUSD7,516,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

5,758,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

4,578,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

4,829,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Depreciation, Amortization and Accretion, NetUSD62,446,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

65,503,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

60,022,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

56,661,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Equity Securities, FV-NI, Unrealized Gain (Loss)USD-1,000,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

———
Foreign Currency Transaction Gain (Loss), before TaxUSD-100,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-1,200,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-700,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-3,200,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), UnrealizedUSD134,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

2,770,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

212,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-1,108,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Gain (Loss) on InvestmentsUSD-867,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

127,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

465,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

70,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

GoodwillUSD45,815,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

As of 2025-12-31

52,815,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

As of 2024-12-31

52,815,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

As of 2023-12-31

52,815,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

As of 2022-12-31

Goodwill, Impairment LossUSD7,000,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

—
Income (Loss) from Equity Method InvestmentsUSD———0
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD17,767,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

4,996,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

13,051,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

10,108,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Induced Conversion of Convertible Debt ExpenseUSD15,264,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

———
InterestExpenseNonoperatingUSD7,362,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

8,084,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——
Inventory Write-downUSD261,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

359,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

542,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

741,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Investment Income, InterestUSD2,800,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

2,180,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——
Net Income (Loss) Attributable to ParentUSD34,876,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

26,059,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

25,335,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-22,800,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD4,005,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

5,291,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——
Financing Receivable, Credit Loss, Expense (Reversal)USD-60,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

572,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Total RevenueUSD410,212,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

352,208,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

374,839,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

300,805,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Cost of RevenueUSD164,022,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

162,008,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

160,498,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

144,450,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Selling, General and Administrative ExpenseUSD138,455,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

132,701,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

144,406,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

138,043,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Operating Income (Loss)USD84,229,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

43,862,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

50,398,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-4,834,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD63,293,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

37,698,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

46,117,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD17,767,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

4,996,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

13,051,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

10,108,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD34,876,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

26,059,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

25,335,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-22,800,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share0.65
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

0.49
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

0.47
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-0.4
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share0.63
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

0.48
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

0.46
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-0.4
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares53,636,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

52,650,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

54,310,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

56,674,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares55,544,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

53,864,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

55,146,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

56,674,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD7,362,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

8,084,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——
Additional Financial Items
Amortization of Intangible AssetsUSD7,516,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

5,758,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

4,578,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

4,829,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Business Combination, Acquisition Related CostsUSD———1,100,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Current Income Tax Expense (Benefit)USD16,995,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

10,627,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

14,498,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

12,181,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), before TaxUSD-100,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

-1,200,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

-700,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

-3,200,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Gain (Loss) on InvestmentsUSD-867,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

127,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

465,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

70,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Goodwill, Impairment LossUSD7,000,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

—
Gross ProfitUSD246,190,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

190,200,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

214,341,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

156,355,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD-2,032,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

———
Income (Loss) from Equity Method InvestmentsUSD———0
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Interest ExpenseUSD——6,821,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

5,877,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Interest Income, OperatingUSD——2,486,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

1,428,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Investment Income, InterestUSD2,800,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

2,180,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

——
Marketing and Advertising ExpenseUSD———21,757,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost ComponentUSD243,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

387,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

411,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

556,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD5,816,000
Source

10-K · 2026-02-25 · 0001628280-26-011770

2025-01-01 to 2025-12-31

5,103,000
Source

10-K · 2025-02-19 · 0000921582-25-000008

2024-01-01 to 2024-12-31

10,110,000
Source

10-K · 2024-02-27 · 0000950170-24-021327

2023-01-01 to 2023-12-31

5,300,000
Source

10-K · 2023-02-22 · 0000950170-23-003801

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

d788025dex41.htm · 8-K · 2025-11-06

EX-4.1 2 d788025dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 IMAX CORPORATION and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of November 6, 2025 0.750% Convertible Senior Notes due 2030 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction …

8-K · 2025-11-06 · 0001193125-25-270049

Read attachment ↗
d788025dex42.htm · 8-K · 2025-11-06

EX-4.2 3 d788025dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 THIS IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THIS NOTE FOR ALL PURPOSES. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (“DTC”) TO THE COMPANY OR ITS AGENT FOR REGISTRATION…

8-K · 2025-11-06 · 0001193125-25-270049

Read attachment ↗
d788025dex991.htm · 8-K · 2025-11-06

EX-99.1 5 d788025dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 IMAX Corporation Announces Proposed Convertible Senior Notes Offering Opportunistic capital raise for the partial refinancing of outstanding 2026 notes, working capital, share repurchases or other general corporate purposes IMAX to purchase capped calls intended to offset any share dilution until at least a targeted 75% premium to the last reported sale price of IMAX’s common shares on the date of pricing ─────────────────…

8-K · 2025-11-06 · 0001193125-25-270049

Read attachment ↗
d788025dex992.htm · 8-K · 2025-11-06

EX-99.2 6 d788025dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 IMAX Corporation Prices $220 Million Convertible Senior Notes Offering Opportunistic capital raise for the substantial refinancing of outstanding 2026 notes IMAX to purchase capped calls intended to offset any share dilution until a 75% premium to the last reported sale price of IMAX’s common shares on the date of pricing ────────────────────────────────────────────────────────────────────────────────────────────────────────…

8-K · 2025-11-06 · 0001193125-25-270049

Read attachment ↗